NAT/MDx Growth Target NAT and molecular diagnostics labs with scalable oligo synthesis and specialized fluorophores; emphasize end-to-end support from early research through commercialisation and a secure, reliable supply chain.

Global Capacity Position Biosearch across global manufacturing sites to meet early-stage through commercial-scale needs with consistent quality and rapid ramp-up capabilities.

Supply Security Highlight proprietary BHQ quencher and full-spectrum fluorophores as differentiators for robust assay development and dependable supply continuity.

Procurement Access Leverage procurement channels such as SAP Ariba to streamline onboarding, offer preferred supplier status, and align with UK GDPR compliance for multinational customers.

Growth Partnerships Capitalize on LGC growth initiatives, including new facilities and strategic partnerships, to position Biosearch for co-development, reference materials, and regional expansion opportunities.